Medications

'Generic' medical devices could cut into name-brand profits

Generic competition - a billion-dollar problem for brand-name drug companies since the 1980s - is making inroads in the orthopedic medical devices industry. Last week Cardinal Health Inc., one of the three biggest device ...

Diabetes

Dapagliflozin improves glucose outcomes in type 1 diabetes

(HealthDay)—In patients with type 1 diabetes, treatment with dapagliflozin for 24 weeks improves time in range, mean glucose, and glycemic variability, according to a study published online April 9 in Diabetes Care.

Gastroenterology

ChatGPT does not pass American College of Gastroenterology tests

The natural language processing model Chat Generative Pretrained Transformer (ChatGPT) does not pass the American College of Gastroenterology (ACG) Self-Assessment Tests, according to a study published online May 22 in the ...

page 12 from 40